BioRestorative Therapies Announces Metabolic Research Collaboration with University of Pennsylvania
24 sept. 2018 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 24, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Announces Publication of Study Results Validating the Benefits of Using Hypoxic Cultured Cells to Treat Patients with Degenerative Disc Disease
15 août 2018 10h20 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Aug. 15, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Appoints Jason M. Lipetz, M.D. to its Scientific Advisory Board
25 juil. 2018 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., July 25, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Reports Positive Findings from Independent Review of its BRTX-100 Program
11 juin 2018 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., June 11, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Appoints Wayne J. Olan, M.D. as Clinical Director of Regenerative Disc/Spine Program
07 mai 2018 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., May 07, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Announces the Appointment of Adam D. Bergstein as Sr. VP, Planning and Business Development
22 janv. 2018 11h00 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Jan. 22, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in Japan
17 oct. 2017 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Oct. 17, 2017 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Announces Published Study of Licensed Technology to Treat Lumbar Degenerative Disc Disease
05 oct. 2017 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Oct. 05, 2017 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies to Present at 6th Annual Marcum MicroCap Conference
14 juin 2017 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., June 14, 2017 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Receives Notice of Acceptance for Key Metabolic Patent in Australia
20 avr. 2017 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., April 20, 2017 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies,...